Covifenz (virus-like particles (VLP) of SARS-CoV-2 spike protein) - Mitsubishi Tanabe, Laval University, Dynavax, GSK
http://www.ncbi.nlm.nih.gov/pubmed/40483589
 
Andréane Langlois; Dominique Michaud; Francis Poirier-Gravel; Louis-Philippe Hamel; Marc-Andre Comeau; Marc-André D'Aoust; Marie-Claire Goulet; Marie-Ève Paré; Pierre-Olivier Lavoie; Rachel Tardif
 
Jun 8, 2025
 
Next